Navigation Links
Snoasis Medical Initiates Distribution in Japan Through Hausten Healthcare
Date:7/27/2012

DENVER, July 27, 2012 /PRNewswire-iReach/ -- Snoasis Medical, Inc. formally announces the signing of a distribution agreement with Hausten Healthcare, LLC (Honolulu, HI), whereby Hausten Healthcare will distribute BioXclude™ in Japan.  While BioXclude is not approved for use by the Japanese Ministry of Health and Welfare, clinicians may legally import unapproved foreign medical products for treatment of patients in accordance with the Pharmaceutical Affairs Law. 

Hausten Healthcare is expected to begin distribution activities this coming fall.  Highly proficient in managing this unique regulatory landscape, Hausten Healthcare works in conjunction with Japanese clinicians to easily and efficiently navigate the importation process.  According to Robert Tofe, president and founder of Snoasis Medical, "we are currently seeking regulatory approval in Taiwan and South Korea, and are actively working to set up distribution in China.  Our relationship with Hausten allows access to Japan, one of the largest dental markets in the world, and punctuates our efforts to set up distribution throughout East Asia"

Amnion-chorion tissue is often referred to as the amniotic sac, the part of the placenta that encloses and protects the unborn baby through term.  This tissue is considered immunoprivileged, possesses anti-bacterial and anti-microbial properties, reduces inflammation at the wound site, and provides a protein-enriched matrix to naturally facilitate epithelialization and improve overall wound healing.  These attributes provide BioXclude with many benefits over traditional barrier membrane products used by dental professionals in guided bone and tissue regeneration procedures.

Founded in 2007, Snoasis Medical is focused on the development and commercialization of regenerative tissue and medical device products for use in dental surgery.  In 2008, Snoasis obtained the exclusive license and worldwide distribution rights to all current and future placental tissue products processed by Surgical Biologics, A MiMedx Group Company (Kennesaw, GA) for use in dentistry.  Snoasis Medical initiated commercial distribution of BioXclude in the United States in March 2010 and in Canada in September 2010.  For additional information, please visit www.SnoasisMedical.com.

Hausten Healthcare, LLC is a newly formed entity focused on providing Japanese dental clinicians, institutions and patients the best possible tissue regenerative options, some of which are not currently approved by the Japanese Ministry of Health and Welfare.  Created in June 2012, Hausten Healthcare was spun out of RHC Corporation, a company focused on providing Japanese physicians and medical institutions with a greater range of medical treatment options.  

Media Contact: Eric Frank Snoasis Medical, 303-242-8075, efrank@snoasismedical.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Snoasis Medical
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research
2. DiaTech Life Sciences Announces Medical Advisory Board
3. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
4. Breaking Study: ICU Medicals Tego® Needlefree Connector Proves More Cost Effective Than Traditional Central Venous Catheter Locks
5. China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise
6. Varian Medical Systems Schedules First Quarter FY2012 News Release and Conference Call
7. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
8. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
9. Live Press Briefing on Findings of Biomedical Industry CEO Survey
10. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
11. Scott Brooks Joins Regenesis Biomedical as Chief Operating Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... GREENWICH, Connecticut , November 30, 2016 ...   ... Aptuit, LLC today announced ... screening library. An additional 150,000 novel compounds have increased the ... selected to broaden the hit discovery capabilities of the company. ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... technology applications, introduces the 5th generation, ultra-bright, Laser-Driven Light Source, the EQ-77, at ... Source (LDLS™) technology, the EQ-77 offers higher radiance and irradiance from a truly ...
(Date:11/30/2016)... ... , ... With growth rates averaging more than 30% each year, Random42 has ... continuing their expansion in their new office space. The new office has a fantastic ... the creative industries, so Random42 Scientific Communication will fit right in. , Ben ...
(Date:11/30/2016)... November 30, 2016 Teil einer ... ... , Aptuit LLC ... zu haben. Zusätzliche 150.000 neuartige Substanzen haben die Prüfsammlung ... ausgewählt, um die starken Entdeckungsfähigkeiten des Unternehmens zu erweitern. ...
Breaking Biology Technology:
(Date:6/2/2016)... June 2, 2016   The Weather Company , an ... Ads, an industry-first capability in which consumers will be able ... to ask questions via voice or text and receive relevant ... Marketers have long sought an advertising solution ... can be personal, relevant and valuable; and can scale across ...
(Date:6/1/2016)... Favorable Government Initiatives Coupled With ... Identification to Boost Global Biometrics System Market Through 2021  ... report, " Global Biometrics Market By Type, By ... 2011 - 2021", the global biometrics market is projected ... of growing security concerns across various end use sectors ...
(Date:5/20/2016)... May 20, 2016  VoiceIt is excited to ... VoicePass. By working together, VoiceIt and ... VoiceIt and VoicePass take slightly different approaches to ... both security and usability. ... this new partnership. "This marketing and ...
Breaking Biology News(10 mins):